About Glatopa

About Glatopa 

Glatopa 20 mg/mL and Copaxone® 20 mg/mL are both glatiramer acetate injections. The FDA approved Glatopa 20 mg/mL as therapeutically equivalent to Copaxone® 20 mg/mL. This means that Glatopa 20 mg/mL can be substituted for Copaxone® 20 mg/mL.

Glatopa is entirely made in the United States.

Learn more about Glatopa

Learn More About Therapeutic Equivalence

Copaxone Equivalence

Whether you've just been prescribed Glatopa 20 mg/mL by your doctor or have been switched from Copaxone® 20 mg/mL, you're getting the same FDA-approved treatment for your relapsing-forms of multiple sclerosis.

View this chart showing the many ways Glatopa 20 mg/mL and Copaxone® 20 mg/mL are comparable.

Learn more about equivalence to Copaxone® 20 mg/mL

Learn More About Patient Support Services

Patient Services and Support

Everyone can appreciate a little help now and then. GlatopaCare® — our patient support services center — is here for you every step of the way. Simply call your GlatopaCare Representative at 1.855.GLATOPA with any questions of a non-medical nature, such as insurance information, questions about Co-Pay eligibility, or getting in touch with a Nurse Trainer for guidance with injections.

Learn more about patient support services

Click here to enroll in GlatopaCare